<scp>Anti‐CD20</scp> monoclonal antibody therapy in postpartum women with neurological conditions

Annika Anderson, William Rowles, Shane Poole, Ayushi Balan, Carolyn Bevan, Rachel Brandstadter, Andrea I. Ciplea, Joanna A. Cooper, Michelle Fabian, Thomas W. Hale,

Annals of Clinical and Translational Neurology · 2023 · 22 citations · 14 references

DOIFull text

Open access

Abstract

These confirm minimal transfer of mAb into breastmilk. Anti-CD20 mAb therapy stabilizes MS activity before conception to the postpartum period, and postpartum treatments appears to be safe and well-tolerated for both mother and infant.

References

14